Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: HEART TRANSPLANTATION - , . Treffer: 28
2017
Claes, S; Berchtold-Herz, M; Zhou, Q; Trummer, G; Bock, M; Zirlik, A; Beyersdorf, F; Bode, C; Grundmann, S
Towards a cardiac allocation score: a retrospective calculation for 73 patients from a German transplant center.
J CARDIOTHORAC SURG. 2017; 12(1): 14-14.
Doi: 10.1186/s13019-017-0575-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Prenner, G; Wasler, A; Fahrleinter-Pammer, A; Werkgartner, G; Mischinger, HJ; Koter, S; Roller, R; Wagner, D
The role of serum albumin in the prediction of malnutrition in patients at least five yr after heart transplantation.
Clin Transplant. 2014; 28(6):737-742
Doi: 10.1111/ctr.12370
Web of Science
PubMed
FullText
FullText_MUG
2012
Pichler, M; Rainer, PP; Schauer, S; Hoefler, G
Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin.
J Am Coll Cardiol. 2012; 59(11): 1008-1016.
Doi: 10.1016/j.jacc.2011.11.036
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schweiger, M; Vierecke, J; Stiegler, P; Prenner, G; Tscheliessnigg, KH; Wasler, A
Prehospital Care of Left Ventricular Assist Device Patients by Emergency Medical Services.
Prehosp Emerg Care. 2012; 16(4):560-563
Doi: 10.3109/10903127.2012.702192
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2011
Kniepeiss, D; Renner, W; Trummer, O; Wagner, D; Wasler, A; Khoschsorur, GA; Truschnig-Wilders, M; Tscheliessnigg, KH
The role of CYP3A5 genotypes in dose requirements of tacrolimus and everolimus after heart transplantation.
Clin Transplant. 2011; 25(1): 146-150.
Doi: 10.1111/j.1399-0012.2009.01198.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Krabatsch, T; Schweiger, M; Stepanenko, A; Drews, T; Potapov, E; Pasic, M; Weng, Y; Huebler, M; Hetzer, R
Improvements in implantable mechanical circulatory support systems : literature overview and update.
Herz. 2011; 36(7):622-629
Doi: 10.1007/s00059-011-3509-5
Web of Science
PubMed
FullText
FullText_MUG
Krabatsch, T; Schweiger, M; Stepanenko, A; Drews, T; Potapov, E; Vierecke, J; Jurmann, B; Pasic, M; Weng, YG; Huebler, M; Hetzer, R
Technical possibilities and limitations of mechanical circulatory support.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2011; 46(6):414-421
Doi: 10.1055/s-0031-1280746
Web of Science
PubMed
FullText
FullText_MUG
2010
Koestenbauer, S; Stiegler, P; Stadlbauer, V; Mayrhauser, U; Leber, B; Schweiger, M; Wasler, A; Prenner, G; Sereinigg, M; Zelzer, S; Stojakovic, T; Scarpatetti, M; Griesbacher, A; Greilberger, J; Tscheliessnigg, K
Myeloperoxidase and carbonyl proteins: promising markers for non-invasive monitoring of graft rejection after heart transplantation.
J Heart Lung Transplant. 2010; 29(12): 1352-1357.
Doi: 10.1016/j.healun.2010.05.020
Web of Science
PubMed
FullText
FullText_MUG
2009
Fahrleitner-Pammer, A; Piswanger-Soelkner, JC; Pieber, TR; Obermayer-Pietsch, BM; Pilz, S; Dimai, HP; Prenner, G; Tscheliessnigg, KH; Hauge, E; Portugaller, RH; Dobnig, H
Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
J Bone Miner Res. 2009; 24(7): 1335-1344.
Doi: 10.1359/jbmr.090216
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Zelzer, S; Stiegler, P; Kapitan, M; Schaffellner, S; Schweiger, M; Stettin, M; Stojakovic, T; Truschnig-Wilders, M; Tscheliessnigg, KH; Khoschsorur, G
Myeloperoxidase as serum marker for detection of CMV infections and rejections in patients after liver or heart transplantation.
Transpl Immunol. 2009; 20(3): 121-126.
Doi: 10.1016/j.trim.2008.09.014
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2007
Khoschsorur, G; Fruehwirth, F; Zelzer, S; Stettin, M; Halwachs-Baumann, G
Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
CLIN CHIM ACTA. 2007; 380(1-2): 217-221.
Doi: 10.1016/j.cca.2007.01.017
Web of Science
PubMed
FullText
FullText_MUG
2006
Doenst, T; Bugger, H; Leippert, S; Barleon, B; Marme, D; Beyersdorf, F
Differential gene expression in response to ventricular unloading in rat and human myocardium.
Thorac Cardiovasc Surg. 2006; 54(6): 381-387.
Doi: 10.1055/s-2006-924267
Web of Science
PubMed
FullText
FullText_MUG
2004
Giese, T; Zeier, M; Schemmer, P; Uhl, W; Schoels, M; Dengler, T; Buechler, M; Meuer, S
Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A.
Transplantation. 2004; 77(3):339-344
Doi: 10.1097/01.TP.0000109260.00094.01
Web of Science
PubMed
FullText
FullText_MUG
2001
Burkhardt, K; MacGee, W; Tötsch, M; Cox, JN
Amyloidosis of saphenous coronary bypass graft.
Swiss Med Wkly. 2001; 131(33-34): 498-498.
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
Genser, B; Truschnig-Wilders, M; Stünzner, D; Landini, MP; Halwachs-Baumann, G
Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard.
Clin Chem Lab Med. 2001; 39(1):62-70
Doi: 10.1515/CCLM.2001.014
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Hangler, HB; Pfaller, K; Antretter, H; Dapunt, OE; Bonatti, JO
Coronary endothelial injury after local occlusion on the human beating heart.
Ann Thorac Surg. 2001; 71(1):122-127
Doi: 10.1016/S0003-4975(00)02181-0
Web of Science
PubMed
FullText
FullText_MUG
1999
Mehrabi, MR; Ekmekcioglu, C; Tatzber, F; Oguogho, A; Ullrich, R; Morgan, A; Tamaddon, F; Grimm, M; Glogar, HD; Sinzinger, H
The isoprostane, 8-epi-PGF2 alpha, is accumulated in coronary arteries isolated from patients with coronary heart disease.
Cardiovasc Res. 1999; 43(2):492-499
Doi: 10.1016/S0008-6363(99)00108-X
Web of Science
PubMed
FullText
FullText_MUG
1998
Aigner, RM; O'Mara, RE; Fueger, GF; Tscheliessnigg, K; Nicoletti, R; Sorantin, E; Smith, EM
Renography before heart transplantation in patients with cardiomyopathy.
J Nucl Med. 1998; 39(12):2153-2158
[OPEN ACCESS]
Web of Science
PubMed
Khoschsorur, G; Auer, T; Lanzer, G; Petritsch, P; Holzer, H; Tscheliessnigg, KH
The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy.
Angiology. 1998; 49(4):307-314
Doi: 10.1177/000331979804900409
Web of Science
PubMed
FullText
FullText_MUG
1996
Auer, T; Weihs, W; Grasser, B; Schmidt, B; Petutschnigg, B; Wasler, A; Iberer, F; Tscheliessnigg, KH
Donor heart quality control. Analysis of echocardiographic (EC) findings and patient outcome.
Transpl Int. 1996; 9 Suppl 1(3):S409-S413
Doi: 10.1007/978-3-662-00818-8_98
PubMed
FullText
FullText_MUG
Iberer, F; Tscheliessnigg, K; Halwachs, G; Auer, T; Wasler, A; Petutschnigg, B; Schreier, G; Müller, H; Allmayr, T; Prenner, G; Hipmair, G; Grasser, B; Freigassner, M
Cytomegalovirus antigenemia as a marker for antiviral therapy after heart transplantation.
J Heart Lung Transplant. 1996; 15(3):314-315
Web of Science
PubMed
Iberer, F; Tscheliessnigg, K; Halwachs, G; Rehak, P; Wasler, A; Petutschnigg, B; Schreier, G; Müller, H; Allmayer, T; Freigassner, M; Prenner, G; Hipmair, G; Grasser, B
Definitions of cytomegalovirus disease after heart transplantation: antigenemia as a marker for antiviral therapy.
Transpl Int. 1996; 9(3):236-242
Doi: 10.1007/BF00335392
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1993
Iberer, F; Königsrainer, A; Wasler, A; Petutschnigg, B; Auer, T; Tscheliessnigg, K
Cardiac allograft harvesting after carbon monoxide poisoning. Report of a successful orthotopic heart transplantation.
J Heart Lung Transplant. 1993; 12(3):499-500
(- Case Report)
Web of Science
PubMed
Iberer, F; Wasler, A; Tscheliessnigg, K; Petutschnigg, B; Auer, T; Müller, H; Rödl, S
Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation.
J Heart Lung Transplant. 1993; 12(2):173-178
Web of Science
PubMed
Wasler, A; Iberer, F; Tscheliessnigg, KH; Auer, T; Petutschnigg, B
Prostaglandin E1 in the pretransplantation period in patients with pulmonary hypertension.
J Heart Lung Transplant. 1993; 12(5):884-884
Web of Science
PubMed
1989
Zenker, G; Tscheliessnig, KH; Metzler, H; Dakar, D; Mächler, H; Auer, T; Kandlhofer, B; Weihs, W; Rödl, S; Forche, G
[Postoperative behavior of pulmonary artery pressure and right ventricular remodeling following orthotopic heart transplantation].
Wien Med Wochenschr Suppl. 1989; 104(4):suppl 53-suppl 55
PubMed
1970
Kraft-Kinz, J; Friehs, G; Lukas, H
Heart transplantation in animal experiments].
Wien Tierarztl Monatsschr. 1970; 57(5):184-188
PubMed
1969
Kraft-Kinz, J; Friehs, G; Finsterbusch, W; Kock, G; List, W; Dunki, H; Eide, M; Klepp, G
Experimental heart transplantation].
Zentralbl Chir. 1969; 94(49):1651-1658
PubMed